Vertex Pharmaceuticals (VRTX) had the highest return in Q2 2000 by a US stock with a market cap of $100B+, returning 119.8%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Vertex Pharmaceuticals (VRTX) | Q2 2000 | 119.82% |
Eli Lilly and (LLY) | Q2 2000 | 55.97% |
NVIDIA (NVDA) | Q2 2000 | 51.91% |
UnitedHealth (UNH) | Q2 2000 | 44.42% |
Johnson & Johnson (JNJ) | Q2 2000 | 44.25% |
BlackRock (BLK) | Q2 2000 | 43.21% |
Micron Technology (MU) | Q2 2000 | 40.06% |
Advanced Micro Devices (AMD) | Q2 2000 | 30.38% |
Pfizer (PFE) | Q2 2000 | 29.98% |
PepsiCo (PEP) | Q2 2000 | 28.78% |
Stryker (SYK) | Q2 2000 | 27.74% |
Abbott Laboratories (ABT) | Q2 2000 | 25.94% |
Novo Nordisk A-S (NVO) | Q2 2000 | 25.18% |
Lockheed Martin (LMT) | Q2 2000 | 24.23% |
Chubb (CB) | Q2 2000 | 23.68% |
Merck (MRK) | Q2 2000 | 23.32% |
Coca-Cola (KO) | Q2 2000 | 21.96% |
ASML Holding NV ADR (ASML) | Q2 2000 | 21.58% |
S&P Global (SPGI) | Q2 2000 | 20.88% |
Frank's International (FI) | Q2 2000 | 16.3% |
Gilead Sciences (GILD) | Q2 2000 | 15.65% |
Amgen (AMGN) | Q2 2000 | 15.16% |
Adobe Systems (ADBE) | Q2 2000 | 14.97% |
Boeing (BA) | Q2 2000 | 11.17% |
Novartis AG ADR (NVS) | Q2 2000 | 11.11% |
